Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial

Pathogen reduction (PR) technologies for blood components have been established to reduce the residual risk of known and emerging infectious agents. THERAFLEX UV-Platelets, a novel ultraviolet C (UVC) light-based PR technology for platelet concentrates, works without photoactive substances. This ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Brixner, Veronika, Bug, Gesine, Pohler, Petra, Krämer, Doris, Metzner, Bernd, Voß, Andreas, Casper, Jochen, Ritter, Ulrich, Klein, Stefan, Alakel, Nael, Peceny, Rudolf, Derigs, Hans G., Stegelmann, Frank, Wolf, Martin, Schrezenmeier, Hubert, Thiele, Thomas, Seifried, Erhard, Kapels, Hans-Hermann, Döscher, Andrea, Petershofen, Eduard K., Müller, Thomas H., Seltsam, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018132/
https://www.ncbi.nlm.nih.gov/pubmed/33538149
http://dx.doi.org/10.3324/haematol.2020.260430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018132/
https://www.ncbi.nlm.nih.gov/pubmed/33538149
http://dx.doi.org/10.3324/haematol.2020.260430

Ejemplares similares